Supreme Court Decision: What's At Stake for Big Pharma?

Friday, 8 Jun 2012 | 7:17 AM ET

Barbara Ryan, Deutsche Bank Securities senior pharmaceutical analyst, takes a look at the vital signs of big drug companies and weighs in on what to expect from the Supreme Court's ruling on President Obama's health care overhaul plan.